What is Zura Bio Ltd - Ordinary Shares - Class A Annual Net Profit?

Zura Bio Ltd - Ordinary Shares - Class A Annual Net Profit fell 127.35% in the last year to $58.52 M. Its sector's average net profit growth for the last fiscal year was -32.46%.

What is Zura Bio Ltd - Ordinary Shares - Class A Price to Earning Ratio?

Zura Bio Ltd - Ordinary Shares - Class A Price to Earning Ratio is -1.88, which is negative.

What is Zura Bio Ltd - Ordinary Shares - Class A Stock Price?

Zura Bio Ltd - Ordinary Shares - Class A Stock Price fell 43.33% and underperformed its sector by 50.32% in the past year.

What is Zura Bio Ltd - Ordinary Shares - Class A Quarterly Net profit?

Zura Bio Ltd - Ordinary Shares - Class A Quarterly Net profit fell 150.33% YoY to $20.7 M. Its sector's average net profit growth YoY for the quarter was -47.31%.

What is Zura Bio Ltd - Ordinary Shares - Class A Return on Equity(ROE)?

Zura Bio Ltd - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -507.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Zura Bio Ltd - Ordinary Shares - Class A Mutual Fund Holding?

Zura Bio Ltd - Ordinary Shares - Class A Mutual Fund Holding increased by 0.47% in the last quarter to 9.76.

What is Zura Bio Ltd - Ordinary Shares - Class A Institutional Holding?

Zura Bio Ltd - Ordinary Shares - Class A Institutional Holding increased by 9.17% in the last quarter to 66.18.

How is the Zura Bio Ltd - Ordinary Shares - Class A today?

The Zura Bio Ltd - Ordinary Shares - Class A today is trading in the down by -8.72% at 1.36.

How has Zura Bio Ltd - Ordinary Shares - Class A performed historically?

The Zura Bio Ltd - Ordinary Shares - Class A is currently trading down -8.72% on an intraday basis in the past week the index rose 2.26%. The index has been down -41.38% in the past quarter and fell -43.33% in the past year. You can view this in the overview section.

Zura Bio Ltd - Ordinary Shares - Class A XNAS: ZURA

Zura Bio Ltd - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Zura Bio Ltd - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Zura Bio Ltd - Ordinary Shares - Class A
Rating: 0.98933325
Author: Trendlyne DVM scores

Download real time

1.36 -0.13 (-8.72%)

78.58% Fall from 52W High

269.0K XNAS Volume

XNAS 26 Mar, 2025 1:09 PM (EDT)

Zura Bio Ltd - Ordinary Sh... Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	88.8
PE TTM Negative PE TTM Unavailable in chosen country	-1.9
Price to Book Below industry Median Unavailable in chosen country	0.6
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	66.2
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-150.3
Piotroski Score Low in industry Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	-45.5
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-507.8
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-130.5

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

12.8 / 100

Technically Bearish

26.7 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Zura Bio Ltd - Ordinary Sh... Stock Price Analysis

Day Price Range -8.7% 1 Day return Unavailable in chosen country	1.4 (LTP) 1.31.5 LowHigh
Week Price Range 2.3% 1 Week return Unavailable in chosen country	1.4 (LTP) 1.31.6 LowHigh
Month Price Range 6.2% 1 Month return Unavailable in chosen country	1.4 (LTP) 1.11.6 LowHigh
52 Week Price Range -43.3% 1 Year return Unavailable in chosen country	1.4 (LTP) 1.16.4 LowHigh

View full Share Price History

Zura Bio Ltd - Ordinary Sh... Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Zura Bio Ltd - Ordinary Sh... Stock Analysis

Zura Bio Ltd - Ordinary Sh... stock analysis with key metrics, changes, and trends.

Zura Bio Ltd - Ordinary Sh... Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$58.52 M	127.35%	negative	Annual Net Profit fell 127.35% in the last year to $58.52 M. Its sector's average net profit growth for the last fiscal year was -32.46%.
Price to Earning Ratio	-1.88	-	negative	Price to Earning Ratio is -1.88, which is negative.
Stock Price	$1.36	-43.33%	negative	Stock Price fell 43.33% and underperformed its sector by 50.32% in the past year.
Quarterly Net profit	$20.7 M	150.33%	negative	Quarterly Net profit fell 150.33% YoY to $20.7 M. Its sector's average net profit growth YoY for the quarter was -47.31%.
Return on Equity(ROE)	-507.76 %	-507.76%	negative	Return on Equity(ROE) for the last financial year was -507.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	9.76 %	0.47%	positive	Mutual Fund Holding increased by 0.47% in the last quarter to 9.76.
Institutional Holding	66.18 %	9.17%	positive	Institutional Holding increased by 9.17% in the last quarter to 66.18.

VIEW LESS

Loading data..

Zura Bio Ltd - Ordinary Shares - Class A - Company Profile

What does Zura Bio Ltd - Ordinary Shares - Class A do?

Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Zura Bio Ltd - Ordinary Shares - Class A Management structure

All Gross Remunerations are in USD

Mr. Robert Lisicki

Chief Executive Officer and Director

2024

Gross Remuneration

Year

Mr. Christopher Cabell, M.D.

Chief Medical Officer and Executive Vice President

2024

Gross Remuneration

Year

Dr. Kiran Nistala, M.B.B.S.,PhD

Executive Vice President, Development and Chief Medical Officer

2024

Gross Remuneration

Year

Dr. Michael Howell, PhD

Chief Scientific Officer

2024

Gross Remuneration

Year

Zura Bio Ltd - Ordinary Shares - Class A Board of directors

All Gross Remunerations are in USD

Mr. Robert Lisicki

Chief Executive Officer and Director

2024

Gross Remuneration

Year

Dr. Someit Sidhu, M.D.

Director

2024

Gross Remuneration

Year

Zura Bio Ltd - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

78.58% Fall from 52W High

Zura Bio Ltd - Ordinary Sh... Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Zura Bio Ltd - Ordinary Sh... Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Zura Bio Ltd - Ordinary Sh... Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Zura Bio Ltd - Ordinary Sh... Stock Analysis

Zura Bio Ltd - Ordinary Sh... stock analysis with key metrics, changes, and trends.

Annual Net Profit fell 127.35% in the last year to $58.52 M. Its sector's average net profit growth for the last fiscal year was -32.46%.

Price to Earning Ratio is -1.88, which is negative.

Stock Price fell 43.33% and underperformed its sector by 50.32% in the past year.

Quarterly Net profit fell 150.33% YoY to $20.7 M. Its sector's average net profit growth YoY for the quarter was -47.31%.

Return on Equity(ROE) for the last financial year was -507.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.47% in the last quarter to 9.76.

Institutional Holding increased by 9.17% in the last quarter to 66.18.

Zura Bio Ltd - Ordinary Shares - Class A - Company Profile

What does Zura Bio Ltd - Ordinary Shares - Class A do?

Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Zura Bio Ltd - Ordinary Shares - Class A Management structure

Mr. Robert Lisicki

Chief Executive Officer and Director

Mr. Christopher Cabell, M.D.

Chief Medical Officer and Executive Vice President

Dr. Kiran Nistala, M.B.B.S.,PhD

Executive Vice President, Development and Chief Medical Officer

Dr. Michael Howell, PhD

Chief Scientific Officer

Zura Bio Ltd - Ordinary Shares - Class A Board of directors

Mr. Robert Lisicki

Chief Executive Officer and Director

Dr. Someit Sidhu, M.D.

Director

Zura Bio Ltd - Ordinary Shares - Class A FAQ

How is Zura Bio Ltd - Ordinary Shares - Class A today?

Zura Bio Ltd - Ordinary Shares - Class A today is trading in the red, and is down by -8.72% at 1.36.

How has Zura Bio Ltd - Ordinary Shares - Class A performed historically?

Zura Bio Ltd - Ordinary Shares - Class A is currently trading down -8.72% on an intraday basis. In the past week the stock rose 2.26%. stock has been down -41.38% in the past quarter and fell -43.33% in the past year. You can view this in the overview section.